Molecular Partners AG(MOLN) - 2021 Q4 - Annual Report

EXHIBIT 99.1 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021 Research & Development Highlights: Leadership & Governance: Financial: ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN, NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built proteins known as DARPin therapeutics, today announced its corporate highlights ...